glutathione inhibitor Ezatiostat hydrochloride | analog | 286942-97-0 JCI - Hepatic glutathione depletion

Nambi S, Long JE, Mishra BB, Baker R, Murphy KC, Olive AJ, Nguyen HP, Shaffer SA, Sassetti CM

This adverse effect has not yet been clinically reported Hypopigmented patches, especially on sun-exposed areas have been observed after 1012 doses of intravenous injection by practitioners (unpublished observations)

The FDA is responding to the science, the demand, and the voices of practitioners who have been advocating for safer, more transparent access

However, ATP production is dependent on the muscles ability to utilize fuel stores in the body, which is dependent on oxygen availability

No mobile doctor visits required Everything evaluations, follow-ups, dose changes, support, and medication management is done via secure telemedicine